Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chiron Acknowledges Potential Gaps In Influenza Vaccine Distribution

Executive Summary

Chiron agrees with the Government Accountability Office that some influenza vaccine distribution inadequacies may need to be addressed

You may also be interested in...



Aventis Fluzone Distribution Will Be Monitored In Partnership With CDC

Sanofi-Aventis will be working with the Centers for Disease Control & Prevention to monitor distribution of about 25.4 mil. remaining doses of Fluzone to U.S. providers

Flu Vaccine Shortage Shows Hazards Of Market Concentration – Sen. Leahy

The Bush Administration should have "learned their lesson" from last year's influenza vaccine shortages, Sen. Patrick Leahy (D-Vt.) says

Aventis Fluzone Distribution Will Be Monitored In Partnership With CDC

Sanofi-Aventis will be working with the Centers for Disease Control & Prevention to monitor distribution of about 25.4 mil. remaining doses of Fluzone to U.S. providers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel